Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation Correction: After Resuscitation-2 (RADAR-2) randomised clinical trial.

Saved in:
Bibliographic Details
Title: Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation Correction: After Resuscitation-2 (RADAR-2) randomised clinical trial.
Authors: Silversides JA; Department of Critical Care, Belfast Health and Social Care Trust, Belfast, UK. j.silversides@qub.ac.uk.; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Lisburn Road, Belfast, BT9 7BL, UK. j.silversides@qub.ac.uk., McMullan R; Department of Critical Care, Belfast Health and Social Care Trust, Belfast, UK., Emerson LM; School of Health Sciences, City, University of London, London, UK., Bradbury I; Independent Consulting Statistician, Aviemore, UK., Bannard-Smith J; Department of Critical Care, Manchester University NHS Foundation Trust, Manchester, UK.; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK., Szakmany T; Critical Care Directorate, Aneurin Bevan University Health Board, Newport, UK.; Department of Anaesthesia, Intensive Care and Pain Medicine, Cardiff University, Cardiff, UK., Trinder J; Intensive Care Unit, South-Eastern Health and Social Care Trust, Dundonald, UK., Rostron AJ; Integrated Critical Care Unit, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Johnston P; Intensive Care Unit, Northern Health and Social Care Trust, Antrim, UK., Ferguson AJ; Department of Critical Care, Belfast Health and Social Care Trust, Belfast, UK., Boyle AJ; Department of Critical Care, Belfast Health and Social Care Trust, Belfast, UK.; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Lisburn Road, Belfast, BT9 7BL, UK.; Intensive Care Unit, Northern Health and Social Care Trust, Antrim, UK., Blackwood B; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Lisburn Road, Belfast, BT9 7BL, UK., Marshall JC; Keenan Research Centre for Biomedical Science, Unity Health Toronto, Toronto, Canada.; Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada., McAuley DF; Department of Critical Care, Belfast Health and Social Care Trust, Belfast, UK.; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University of Belfast, Lisburn Road, Belfast, BT9 7BL, UK.
Source: Intensive care medicine [Intensive Care Med] 2023 Nov; Vol. 49 (11), pp. 1440.
Publication Type: Published Erratum
Journal Info: Publisher: Springer Verlag Country of Publication: United States NLM ID: 7704851 Publication Model: Print Cited Medium: Internet ISSN: 1432-1238 (Electronic) Linking ISSN: 03424642 NLM ISO Abbreviation: Intensive Care Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-1238
DOI:10.1007/s00134-023-07174-w